Most Recent
Former top silk Norman O'Bryan will face court this month on charges following civil findings he engaged in a fraudulent scheme as senior counsel for the Banksia Securities class action.
A personal injury firm that lost out to a class action heavyweight in a contest to run a case against Toyota unit Hino has dropped its appeal and will wear the costs it incurred in bringing its case.
A former EY partner who was ousted after the tax office claimed he had promoted a $700,000 tax exploitation scheme has argued he is entitled to claim privilege over communications with the accounting firm's general counsel and an external barrister, despite EY having waived it.
A judge has rejected AFL great Phil Krakouer’s request for extensive game footage before putting on an amended claim in a racial vilification class action against the league, which is expected to bring five clubs into the proceeding.
Australian wine company McGuigan has lost its bid to trade mark 'Black Label' for its wine after Johnnie Walker, which makes the popular Black Label whiskey, successfully argued it would cause consumer confusion.
Buoyed by the recent trial success of CBA and other companies facing shareholder ire, building materials giant Boral is taking its chances at a hearing in a class action alleging disclosure breaches linked to its US windows business.
A judge has signed off on a $230 million settlement of a class action on behalf of thousands of junior doctors who allege they were systemically underpaid by the NSW government.
Contractor Kingfisher Mobile has dropped a claim against Telstra in a $45 million lawsuit alleging the telco breached a November 2022 contract when it engaged a new provider to take over.
The consumer regulator must identify the advertisements it relies on to prove its case against Meta over scam cryptocurrency ads on Facebook, with a judge saying the social media giant should know the case it has to meet.
Deciding an “unusually difficult” costs application, a judge has declined to award Monsanto all of its costs for defending a class action alleging its Roundup weed killer is carcinogenic, saying the agrochemical giant should have pushed harder for a split trial.